Aripiprazole Lauroxil
Brand name: Aristada
Rank #168 of 500 drugs by total cost
$93.3M
Total Cost
31,120
Total Claims
$93.3M
Total Cost
1,213
Prescribers
$2,999
Cost per Claim
917
Beneficiaries
35,955
30-Day Fills
$77K
Avg Cost/Provider
26
Avg Claims/Provider
About Aripiprazole Lauroxil
Aripiprazole Lauroxil (sold as Aristada) was prescribed 31,120 times by 1,213 Medicare Part D providers in 2023, costing the program $93.3M. At $2,999 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 165 | Levetiracetam (Levetiracetam) | $96.1M | 1,723,736 |
| 166 | Oxycodone Myristate (Xtampza Er) | $96.1M | 141,266 |
| 167 | Sevelamer Carbonate (Sevelamer Carbonate) | $95.6M | 277,192 |
| 168 | Aripiprazole Lauroxil (Aristada) | $93.3M | 31,120 |
| 169 | Trazodone Hcl (Trazodone Hcl) | $92.6M | 7,273,528 |
| 170 | Insulin Glargine/Lixisenatide (Soliqua 100-33) | $92.5M | 82,886 |
| 171 | Latanoprost (Latanoprost) | $92.3M | 4,388,601 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology